Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03663166 · TERMINATED
Trial details
- NCT number
- NCT03663166
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2021-10-22
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.